Dustin Snelling, MD
Family Medicine · Sioux Falls, SDNPI 1174501043
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.9% of the total across 273 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 10.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,005 and has fallen 62.5% since, to $377 in 2025. Among family medicine clinicians in SD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 273 payments — averaging $13.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$393
- Merck$363
- AbbVie$345
- Novo Nordisk$321
- AstraZeneca$271
- Lilly USA, LLC$265
- plus $2K from 29 others
What the payments were for
- Food & beverage$3,65498%
- Education$792%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 26 | $393 |
| Merck | 33 | $363 |
| AbbVie(2 entities) | 23 | $345 |
| Novo Nordisk | 22 | $321 |
| AstraZeneca | 10 | $271 |
| Lilly USA, LLC | 15 | $265 |
| Astellas Pharma US Inc | 20 | $211 |
| Pfizer | 26 | $204 |
| Sunovion Pharmaceuticals Inc. | 18 | $171 |
| Johnson & Johnson | 10 | $146 |
| Teva Pharmaceuticals USA, Inc. | 9 | $127 |
| Boehringer Ingelheim | 8 | $127 |
| Sanofi-aventis U.S. LLC | 7 | $88 |
| Phathom Pharmaceuticals, Inc. | 6 | $80 |
| GSK | 6 | $80 |
| Daiichi Sankyo Inc. | 4 | $73 |
| Amarin Pharma, Inc. | 4 | $59 |
| E.r. Squibb & Sons, L.L.C. | 3 | $45 |
| Grifols USA, LLC | 3 | $42 |
| Eisai Inc. | 2 | $30 |
| Actelion Pharmaceuticals US, Inc. | 2 | $29 |
| Viatris Specialty LLC | 1 | $28 |
| Idorsia Pharmaceuticals US Inc | 2 | $28 |
| Dynavax Technologies Corporation | 2 | $28 |
| Novartis | 1 | $19 |
| Medtronic | 1 | $18 |
| Biohaven Pharmaceuticals, Inc. | 1 | $18 |
| Abbott | 1 | $18 |
| Inspire Medical Systems, Inc. | 1 | $17 |
| Insmed, Inc. | 1 | $17 |
| Impel Pharmaceuticals Inc. | 1 | $15 |
| Mylan Specialty L.p. | 1 | $15 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $15 |
| Almatica Pharma LLC | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYMBICORT$109
- FARXIGA$109
- BEVESPI AEROSPHERE$109
How this compares
$3,733 in reported general payments places this provider in the 95th percentile of 408 family medicine providers in South Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 151 | $149,659 |
| JardianceEmpagliflozin | 96 | $100,810 |
| XareltoRivaroxaban | 57 | $61,905 |
| EliquisApixaban | 85 | $60,048 |
| JanuviaSitagliptin Phosphate | 42 | $40,261 |
| FarxigaDapagliflozin Propanediol | 40 | $30,913 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 34 | $27,444 |
| TrulicityDulaglutide | 11 | $19,590 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 11 | $16,303 |
| Xultophy 100-3.6Insulin Degludec/Liraglutide | 12 | $14,797 |
| MounjaroTirzepatide | 12 | $13,675 |
| GlyxambiEmpagliflozin/Linagliptin | 21 | $11,071 |
| MyrbetriqMirabegron | 19 | $10,966 |
| SymbicortBudesonide/Formoterol Fumarate | 30 | $7,936 |
| Rosuvastatin Calcium | 579 | $7,111 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Xultophy 100-3.6 | $321 | $164,455163 claims |
| Boehringer IngelheimJardiance, Glyxambi | $127 | $111,881117 claims |
| Johnson & JohnsonXarelto | $146 | $61,90557 claims |
| PfizerEliquis | $204 | $60,04885 claims |
| MerckJanuvia, Janumet Xr | $363 | $56,56353 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Incruse Ellipta, Arnuity Ellipta | $80 | $41,41774 claims |
| AstraZenecaFarxiga, Symbicort | $271 | $38,84970 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $265 | $33,26523 claims |
| Astellas Pharma US IncMyrbetriq | $211 | $10,96619 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 408 family medicine providers in South Dakota.
Other family medicine in Sioux Falls
- Andrew BurchettSioux Falls$13K
- Lornell HansenSioux Falls$11K
- Jeffry MeyerSioux Falls$8K
- Scott BoyensSioux Falls$6K
- Jason WurthSioux Falls$4K
- William BuchnerSioux Falls$3K
- Jennifer SchrieverSioux Falls$2K
- Sabrina TaylorSioux Falls$2K
- Nicole MourelatosSioux Falls$2K
- Joseph MowerySioux Falls$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.